Top segments and regional performance

Last year, the company generated ‪48.13 M‬ CAD, the most of which — ‪25.17 M‬ CAD — came from its top-performing segment, International Medical Cannabis, compared to ‪17.64 M‬ CAD the previous year. The greatest contribution came from Canada, which accounted for ‪19.76 M‬ CAD last year, with ‪24.15 M‬ CAD the year before.